|
|
| ECZ4023 | Pharmaceutical Care - I | 2+0+0 | ECTS:3 | | Year / Semester | Fall Semester | | Level of Course | Second Cycle | | Status | Compulsory | | Department | DEPARTMENT of PHARMACEUTICS | | Prerequisites and co-requisites | None | | Mode of Delivery | Face to face | | Contact Hours | 14 weeks - 2 hours of lectures per week | | Lecturer | Dr. Öğr. Üyesi Mefküre DURMUŞ | | Co-Lecturer | Dr. Yeşim Kaya Yaşar | | Language of instruction | Turkish | | Professional practise ( internship ) | None | | | | The aim of the course: | | To give information about clinical pharmacy and pharmaceutical care, to inform about the role pharmacists in the management of highly-prevalent-diseases |
| Learning Outcomes | CTPO | TOA | | Upon successful completion of the course, the students will be able to : | | | | LO - 1 : | define clinical pharmacy and pharmacutical care | 6 - 7 - 10 | 1, | | LO - 2 : | know correctly how to use of pharmaceutical dosage forms
| 6 - 7 - 10 | 1, | | LO - 3 : | categorise drug-drug interactions by giving examples
| 6 - 7 - 10 | 1, | | LO - 4 : | define Advers Drug Reactions | 6 - 7 - 10 | 1, | | LO - 5 : | learn the role of pharmacist in therapies of highly prevalent-diseases | 6 - 7 - 10 | 1, | | CTPO : Contribution to programme outcomes, TOA :Type of assessment (1: written exam, 2: Oral exam, 3: Homework assignment, 4: Laboratory exercise/exam, 5: Seminar / presentation, 6: Term paper), LO : Learning Outcome | | |
| Clinical pharmacy and pharmaceutical care of basic information about the clinical base in pharmaceutical applications, Drug-drug interactions and Advers Drug Reactions, Pharmaceutical care for Kardiovascular diseases, Pharmaceutical care for Dermatological disorders, Pharmaceutical care for Endocrine diseases,Pharmaceutical care for Joint disorders and urinary tract infections |
| |
| Course Syllabus | | Week | Subject | Related Notes / Files | | Week 1 | Pharmaceutical Care and Clinical Pharmacy
| | | Week 2 | Drug Applications | | | Week 3 | Drug-drug interactions and Advers Drug Reactions
| | | Week 4 | Pharmaceutical care for cardiovascular diseases: Hypertension, Dislipidemia, Thrombosis.
| | | Week 5 | Pharmaceutical care for cardiovascular diseases-1: Hypertension, Dislipidemia, Thrombosis.
| | | Week 6 | Pharmaceutical care for cardiovascular diseases-2: Congestive heart failure, Arrhythmia | | | Week 7 | Pharmaceutical care for Endocrine diseases: Diabetes | | | Week 8 | Pharmaceutical care for Endocrine diseases: Diabetes | | | Week 9 | Exam | | | Week 10 | Pharmaceutical care for Endocrine diseases: Osteoporozis | | | Week 11 | Pharmaceutical care for joint Disorders | | | Week 12 | Pharmaceutical care for Dermatological disorders: Acute cellulitis, Psoriasis, Acne vulgaris
| | | Week 13 | Pharmaceutical care for infective diseases and basic therapeutic approaches | | | Week 14 | Pharmaceutical care for infective diseases: urinary tract diseases | | | Week 15 | Vaccines and the importance of vaccines in the infective diseases | | | Week 16 | Quiz | | | |
| 1 | Walker, R., Whittlesea C., Clinical Pharmacy and Therapeutics, 5th edition, Elsevier | | | |
| 1 | Oguz Kayaalp Akılcıl Tedavi Yöünden Tıbbi Farmakoloji I-II | | | |
| Method of Assessment | | Type of assessment | Week No | Date | Duration (hours) | Weight (%) | | Mid-term exam | 9 | 03/12/2023 | 1 | 50 | | End-of-term exam | 16 | 19/01/2024 | 1 | 50 | | |
| Student Work Load and its Distribution | | Type of work | Duration (hours pw) | No of weeks / Number of activity | Hours in total per term | | Yüz yüze eğitim | 3 | 14 | 42 | | Arasınav için hazırlık | 3 | 6 | 18 | | Arasınav | 1 | 1 | 1 | | Dönem sonu sınavı için hazırlık | 3 | 6 | 18 | | Dönem sonu sınavı | 1 | 1 | 1 | | Total work load | | | 80 |
|